|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 187.39 USD | +0.33% |
|
+5.11% | +7.66% |
| 06:25pm | Sonora Quest and Laboratory Sciences of Arizona announce Jennifer Erickson as CEO-elect | RE |
| 01-13 | Baird Adjusts Quest Diagnostics Price Target to $203 From $198, Maintains Neutral Rating | MT |
| Capitalization | 20.78B 17.83B 16.6B 15.45B 28.83B 1,876B 31.08B 191B 75.08B 897B 77.92B 76.32B 3,288B | P/E ratio 2025 * |
21.7x | P/E ratio 2026 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise value | 26.14B 22.43B 20.89B 19.44B 36.27B 2,360B 39.1B 240B 94.47B 1,129B 98.04B 96.02B 4,137B | EV / Sales 2025 * |
2.38x | EV / Sales 2026 * | 2.27x |
| Free-Float |
67.83% | Yield 2025 * |
1.65% | Yield 2026 * | 1.67% |
Last Transcript: Quest Diagnostics Incorporated
| 1 day | +0.33% | ||
| 1 week | +5.11% | ||
| Current month | +7.66% | ||
| 1 month | +1.48% | ||
| 3 months | -0.28% | ||
| 6 months | +12.26% | ||
| Current year | +7.66% |
| 1 week | 173.51 |  | 187.69 |
| 1 month | 171.18 | | 187.69 |
| Current year | 171.18 | | 187.69 |
| 1 year | 148.7 | | 197.55 |
| 3 years | 119.59 | | 197.55 |
| 5 years | 113.36 | | 197.55 |
| 10 years | 59.66 | | 197.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Davis
CEO | Chief Executive Officer | 63 | 03/02/2022 |
Sam Samad
DFI | Director of Finance/CFO | 56 | 11/07/2022 |
Kristin Wallace
CMP | Compliance Officer | - | 01/08/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Pfeiffer
BRD | Director/Board Member | 76 | 01/12/2004 |
Timothy Ring
BRD | Director/Board Member | 69 | 07/12/2011 |
James Davis
CHM | Chairman | 63 | 01/04/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -4.10% | 14.84% | 303 M€ | |
| 0.00% | 2.17% | 2 M€ | |
| 0.00% | 2.05% | 5 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.33% | +5.11% | +24.28% | +26.62% | 20.78B | |
| +0.04% | +0.02% | +56.44% | +85.47% | 109B | |
| -0.10% | -1.87% | +51.69% | -11.50% | 101B | |
| -3.41% | 0.00% | +40.58% | +74.26% | 34.12B | |
| -0.46% | +4.94% | -13.25% | +18.14% | 24.3B | |
| +0.51% | +2.99% | +10.53% | +2.95% | 21.72B | |
| +0.70% | -3.92% | +50.25% | +268.28% | 17.15B | |
| -0.64% | -1.45% | +48.22% | +53.39% | 16.55B | |
| -1.34% | -6.74% | -17.71% | +7.19% | 12.04B | |
| +0.48% | -5.33% | +8.88% | +36.40% | 12.45B | |
| Average | -0.42% | +0.61% | +25.99% | +56.12% | 36.91B | |
| Weighted average by Cap. | -0.35% | +1.20% | +39.90% | +48.22% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 10.99B 9.43B 8.78B 8.17B 15.25B 993B 16.44B 101B 39.73B 475B 41.23B 40.38B 1,740B | 11.39B 9.77B 9.1B 8.47B 15.8B 1,028B 17.03B 105B 41.14B 492B 42.7B 41.82B 1,802B |
| Net income | 982M 843M 785M 730M 1.36B 88.65B 1.47B 9.02B 3.55B 42.41B 3.68B 3.61B 155B | 1.05B 902M 840M 781M 1.46B 94.87B 1.57B 9.65B 3.8B 45.38B 3.94B 3.86B 166B |
| Net Debt | 5.36B 4.6B 4.29B 3.99B 7.44B 484B 8.02B 49.28B 19.39B 232B 20.12B 19.71B 849B | 5.09B 4.37B 4.07B 3.79B 7.07B 460B 7.62B 46.79B 18.41B 220B 19.1B 18.71B 806B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/01/26 | 186.80 $ | +0.02% | 78,626 |
| 14/01/26 | 186.77 $ | +3.78% | 1,498,946 |
| 13/01/26 | 179.96 $ | +2.28% | 1,069,588 |
| 12/01/26 | 175.94 $ | +0.86% | 695,248 |
| 09/01/26 | 174.44 $ | -1.86% | 942,357 |
Delayed Quote Nyse, January 15, 2026 at 06:56 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DGX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition